Interaction of Momordica Charantia with metformin in diabetic rats

American Journal of Pharmacology and Toxicology

Volumn 8, Issue 3, 2013, Pages 102-106

  Poonam, Tripathi ^a   Prem Prakash, Gupta ^b   Vijay Kumar, Lal ^c  

^a Pharmacy UTU ^*  (United Kingdom)

^b BRD MEDICAL COLLEGE   (India)

^c Sagar Institute of Technology and Management   (India)

Author keywords

Herb drug interaction; Metformin; Momordica charantia; Synergistic effect

Indexed keywords

GLUCOSE; METFORMIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG MEGADOSE; FRUIT JUICE; GLUCOSE BLOOD LEVEL; HERB DRUG INTERACTION; LOW DRUG DOSE; MOMORDICA CHARANTIA; NONHUMAN; PHARMACODYNAMICS; RAT;

EID: 84892401743     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2013.102.106     Document Type: Article

References (21)

1. Abascal, K. and E. Yarnell, 2005. Using bitter melon to treat diabetes. J. Altern. Comple. Med., 1: 179-184. DOI: 10.1089/act.2005.11.179
2. Adriane, F.B., 2000. Herb-drug interactions. Lancet, 355: 134-138. DOI: 10.1016/S0140-6736(99)06457-0
3. Aragao, D.M.O., L.J. Guarize, D.A. Lanini, J.C. Costa and R.M.G. Garcia et al., 2010. Hypoglycemic effects of Cecropia pachystachya in normal and alloxan-induced diabetic rats. J. Ethnopharmacol., 128: 629-633. PMID: 20064597
4. Atta-Ur-Rahman and K. Zaman, 1989. Medicinal plants with hypoglycemic activity. J. Ethnopharmacol., 26: 1-55. DOI: 10.1016/0378-8741(89)90112-8
5. Balamurugan, R., V. Duraipandiyan and S. Ignacimuthu, 2011. Antidiabetic activity of γ-sitosterol isolated from Lippia nodiflora L. in streptozotocin induced diabetic rats. Eur. J. Pharmacol., 667: 410-418. PMID: 21658378
6. Cefalu, W.T., J. Ye and Z.Q. Wang, 2008. Efficacy of dietary supplementation with botanicals on carbohydrate metabolism in humans. Endocr. Metab. Immune. Disord. Drug. Targets, 8: 78-81. PMID: 18537692
7. Dallak, M., M. AlKhateeb, M. Abbas, R. Elessa, and F. Al-Hashem et al., 2009. In vivo, acute, normohypoglycemic, antihyperglycemic, insulinotropic actions of orally administered ethanol extract of Citrullus colocynthis (L.) Schrab Pulp. Am. J. Biochem. Biotechnol., 5: 118-125. DOI: 10.3844/ajbbsp.2009.118.125
8. Esposito, K., G. Bellastella and D. Giugliano, 2011. When metformin fails in Type 2 diabetes mellitus. Arch. Int. Med., 171: 365-366. PMID: 21357815
9. Gohil, K.L. and J.A. Patel, 2007. Herb-drug interactions: A review and study based on assessment of clinical case reports in literature. Ind. J. Pharmacol., 39: 129-139.
10. Golay, A., 2008. Metformin and body weight. Int. J. Obes., 32: 61-72. DOI: 10.1038/sj.ijo.0803695
11. Grover, J.K. and S.P. Yadav, 2004. Pharmacological actions and potential uses of Momordica charantia: A review. J. Ethnopharmacol., 93: 123-132. PMID: 15182917
12. Grover, J.K., S. Yadav and V. Vats, 2002. Medicinal plants of India with anti-diabetic potential. J. Ethnopharmacol., 81: 81-100. PMID: 12020931
13. Hasan, I. and S. Khatoon, 2012. Effect of momordica charantia (bitter gourd) tablets in diabetes mellitus: Type 1 and Type 2. Prime Res. Med., 2: 72-74.
14. Lans, CA., 2006. Ethnomedicines used in trinidad and tobago for urinary problems and diabetes mellitus. J. Ethnobiol. Ethnomed., 2: 45-45. PMID: 17040567
15. Paul, A. and S.S. Raychaudhuri, 2010 Medicinal uses and molecular identification of two Momordica charantia varieties-a review. Electr. J. Biol., 6: 43-51.
16. Platel, K. and K. Srinivasan, 1997. Plant foods in the management of diabetes mellitus: Vegetables as potential hypoglycaemic agents. Nahrung, 41: 68-74. PMID: 9188186
17. Sancheti, S., S. Sancheti and S.Y. Seo, 2009. Chaenomeles Sinensis: A potent α-and β-glucosidase inhibitor. Am. J. Pharmacol. Toxicol., 4: 8-11. DOI: 10.3844/ajptsp.2009.8.11
18. Satyanarayana, S. and E.K. Kilari, 2006. Influence of nicorandil on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits. Mol. Cell. Biochem., 291: 101-105. PMID: 16715184
19. Scarpello, J.H.B. and H.C. Howlett, 2008. Metformin therapy and clinical uses. Diab. Vasc. Dis. Res., 5: 157-167. PMID: 18777488
20. Schramm, T.K., G.H. Gislason, A. Vaag, J.N. Rasmussen and F. Folke et al., 2011. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: A nationwide study. Eur. Heart J., 32: 1900-1908. PMID: 2147113
21. Wright, A.D., C.A. Cull, K.M. Macleod and R.R. Holman, 2006. Hypoglycemia in Type 2 diabetic patients randomized to and maintained on monotherapy with diet, sulfonylurea, Metformin, or insulin for 6 years from diagnosis: UKPDS73. J. Diabetes Complicate, 20: 395-401. PMID: 17070446